Shang Hai Zheng Quan Bao·2025-09-02 19:15Group 1 - The core viewpoint of the announcement is the resolution of the third extraordinary general meeting of shareholders held by Ningxia Zhongke Biotechnology Co., Ltd. on September 2, 2025, with no resolutions being rejected [1][2]. - The meeting was convened by the company's board of directors and was presided over by Chairman Fu Jie, complying with the provisions of the Company Law and the company's articles of association [2][3]. - All seven current directors attended the meeting, along with the board secretary and senior management [3]. Group 2 - The main agenda item discussed was the proposal regarding the company's new related party relationships and the expected daily related party transactions for the year 2025, which was approved by the shareholders [4]. - The voting results indicated that the proposal was passed with more than half of the voting rights held by attending shareholders or their proxies [4]. - The meeting was witnessed by lawyers from Beijing Dacheng (Yinchuan) Law Firm, who confirmed that the meeting's procedures and voting results were in compliance with legal and regulatory requirements [5].